Novel proteomic technologies to address gaps in pre-clinical ovarian cancer biomarker discovery efforts
IF 3.8
3区 生物学
Q1 BIOCHEMICAL RESEARCH METHODS
引用次数: 0
Abstract
An estimated 20,000 women in the United States will receive a diagnosis of ovarian cancer in 2023. Late-stage diagnosis is associated with poor prognosis. There is a need for novel diagnostic bioma...新型蛋白质组学技术填补临床前卵巢癌生物标志物发现工作的空白
据估计，2023 年美国将有 20,000 名妇女被诊断患有卵巢癌。晚期诊断与预后不良有关。因此需要新型的生物诊断技术。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文
求助全文
来源期刊
Expert Review of Proteomics
生物-生化研究方法
CiteScore
7.60
自引率
0.00%
发文量
20
审稿时长
6-12 weeks
期刊介绍：
Expert Review of Proteomics (ISSN 1478-9450) seeks to collect together technologies, methods and discoveries from the field of proteomics to advance scientific understanding of the many varied roles protein expression plays in human health and disease.
The journal coverage includes, but is not limited to, overviews of specific technological advances in the development of protein arrays, interaction maps, data archives and biological assays, performance of new technologies and prospects for future drug discovery.
The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections:
Expert Opinion - a personal view on the most effective or promising strategies and a clear perspective of future prospects within a realistic timescale
Article highlights - an executive summary cutting to the author''s most critical points.
文献相关原料
| 公司名称 | 产品信息 | 采购帮参考价格 |
|---|
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
